Daida H - Search Results

1

[Positioning of PROactive and its clinical application in Japan--a new direction in diabetes care discussed by diabetology and circulatory disease specialists: discussion].

Kawamori R, Kadowaki T, Daida H, Takeda N, Dormandy J. Kawamori R, et al. Among authors: daida h. Nihon Rinsho. 2006 Mar;64(3):581-7. Nihon Rinsho. 2006. PMID: 16732624 Japanese. No abstract available.

2

Long-term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity.

Yamasaki Y, Katakami N, Furukado S, Kitagawa K, Nagatsuka K, Kashiwagi A, Daida H, Kawamori R, Kaku K. Yamasaki Y, et al. Among authors: daida h. J Atheroscler Thromb. 2010 Nov 27;17(11):1132-40. doi: 10.5551/jat.4663. Epub 2010 Jul 31. J Atheroscler Thromb. 2010. PMID: 20686324 Free article. Clinical Trial.

3

Letter by Watada et al regarding article, "Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesion".

Watada H, Daida H, Kawamori R. Watada H, et al. Among authors: daida h. Circulation. 2008 Oct 28;118(18):e680; author reply e681. doi: 10.1161/CIRCULATIONAHA.108.784025. Circulation. 2008. PMID: 18955674 No abstract available.

4

Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity.

Kaku K, Daida H, Kashiwagi A, Yamashina A, Yamazaki T, Momomura S, Iwase T, Yamasaki Y, Nagatsuka K, Kitagawa K, Kawamori R. Kaku K, et al. Among authors: daida h. Curr Med Res Opin. 2009 Dec;25(12):2925-32. doi: 10.1185/03007990903328124. Curr Med Res Opin. 2009. PMID: 19835463 Clinical Trial.

5

Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.

Azuma K, Toyofuku Y, Iesaki T, Otsuka A, Tanaka A, Mita T, Hirose T, Tanaka Y, Daida H, Kawamori R, Watada H. Azuma K, et al. Among authors: daida h. Biochem Biophys Res Commun. 2006 Jun 30;345(2):688-93. doi: 10.1016/j.bbrc.2006.04.090. Epub 2006 May 2. Biochem Biophys Res Commun. 2006. PMID: 16696939

6

Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).

Kawamori R, Daida H, Tanaka Y, Miyauchi K, Kitagawa A, Hayashi D, Kishimoto J, Ikeda S, Imai Y, Yamazaki T. Kawamori R, et al. Among authors: daida h. BMC Cardiovasc Disord. 2006 Oct 9;6:39. doi: 10.1186/1471-2261-6-39. BMC Cardiovasc Disord. 2006. PMID: 17029631 Free PMC article. Clinical Trial.

7

Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.

Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, Kitagawa A, Kishimoto J, Yamazaki T, Kawamori R. Tanaka Y, et al. Among authors: daida h. Hypertens Res. 2009 Sep;32(9):770-4. doi: 10.1038/hr.2009.96. Epub 2009 Jun 26. Hypertens Res. 2009. PMID: 19557003 Clinical Trial.

8

Management of home blood pressure by amlodipine combined with angiotensin II receptor blocker in type 2 diabetes.

Miyauchi K, Yamazaki T, Watada H, Tanaka Y, Kawamori R, Imai Y, Ikeda S, Kitagawa A, Ono Y, Murayama F, Choi JB, Suwa S, Hayashi D, Kishimoto J, Daida H; ADVANCED-J investigators. Miyauchi K, et al. Among authors: daida h. Circ J. 2012;76(9):2159-66. doi: 10.1253/circj.cj-11-1406. Epub 2012 Jun 9. Circ J. 2012. PMID: 22785573 Free article. Clinical Trial.

9

Association Between Visceral Fat Accumulation and Exercise Tolerance in Non-Obese Subjects Without Diabetes.

Shioya-Yamada M, Shimada K, Nishitani-Yokoyama M, Sai E, Takeno K, Tamura Y, Watada H, Kawamori R, Daida H, Kawai S. Shioya-Yamada M, et al. Among authors: daida h. J Clin Med Res. 2018 Aug;10(8):630-635. doi: 10.14740/jocmr3403w. Epub 2018 Jun 27. J Clin Med Res. 2018. PMID: 29977420 Free PMC article.

10

Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.

Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Nohara R, et al. Among authors: daida h. Circ J. 2012;76(1):221-9. doi: 10.1253/circj.cj-11-0887. Epub 2011 Nov 16. Circ J. 2012. PMID: 22094911 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

786 results

Search Page

Filters